View the OLADX registration information details.
Back to drug list
ItemsDrug Registration information
ID250
No250
Brand NameOLADX
IngredientsOLAPARIB 50 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 56'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OVARIAN CANCER, BREAST CANCER, PANCREATIC CANCER, PROSTATE CANCER
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionLIGHT BLUE CAPSULE CONTAINS WHITE POWDER
Note
License OwnerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
ManufacturerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No08 L 1169/24
FDD Registration Date22/08/2024
Expiry Date21/08/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA